--- title: "FABRICO TECHNOLOGY, INC. — Capability Statement" uei: "YMAJVR21PC43" cage: "4LH67" canonical: "https://teamingindex.com/contractor/YMAJVR21PC43/capability.md" html_url: "https://teamingindex.com/contractor/YMAJVR21PC43" updated: "2026-11-09T17:28:18.052Z" generator: "TeamingIndex capability twin 1.0" legal_name: "FABRICO TECHNOLOGY, INC." dba_name: "FABRICO TECHNOLOGY INC" primary_naics: "541715" sam_status: "active" active_exclusion: false claimed: false tier: "unclaimed" --- # FABRICO TECHNOLOGY, INC. > FABRICO TECHNOLOGY, INC. (DBA FABRICO TECHNOLOGY INC) is a SAM.gov-registered entity based in PFLUGERVILLE, TX 78660-7836. UEI YMAJVR21PC43; CAGE 4LH67; primary NAICS 541715. Compliance posture not provided. Active SAM registration. > **Unclaimed profile:** seeded from SAM.gov and USAspending public records. The entity has not claimed it, so capabilities and compliance posture have not been provided. ## Identifiers - **Legal business name:** FABRICO TECHNOLOGY, INC. - **DBA name:** FABRICO TECHNOLOGY INC - **UEI (SAM.gov Unique Entity ID):** YMAJVR21PC43 - **CAGE code:** 4LH67 - **Entity structure:** Corporate Entity (Not Tax Exempt) - **State of incorporation:** TX - **Website:** Not on file - **TeamingIndex profile:** - **Profile status:** Unclaimed · seeded from SAM.gov and USAspending public records ## Location - **Physical address (city, state, ZIP):** PFLUGERVILLE, TX 78660-7836 - **Country:** United States - **Congressional district:** TX-17 ## NAICS & PSC | NAICS | Title | Primary | Small under SBA size standard (SAM.gov) | | --- | --- | --- | --- | | 541715 | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | Yes | No | - **PSC codes:** None on file Size status is NAICS-specific and reflects the entity’s SAM.gov representations; check it against the size standard of the solicitation’s NAICS code. ## Socio-economic status No socio-economic designations reported in SAM.gov. Source: SAM.gov entity registration, synced 2026-11-09. Confirm current SBA certification (8(a), HUBZone, WOSB/EDWOSB, VetCert SDVOSB/VOSB) before relying on a status for a set-aside. ## SAM registration & exclusion screening - **Registration:** Active SAM registration - **Registration expires:** 2027-01-15 - **Registration activated:** 2026-01-19 - **Exclusion screening (FAR subpart 9.4):** No active exclusion recorded in SAM.gov - **Teaming eligibility:** Eligible to be proposed as a team member (active registration, no exclusion) - **Source:** SAM.gov Entity Management, synced 2026-11-09 ## Compliance posture Compliance posture not provided by the contractor. - Facility clearance: visible to paid members - Clearance levels are shown only to paying members; TeamingIndex does not advertise clearances (NISPOM 32 CFR 117.9). ## Contract vehicles No contract vehicle holdings on file. ## Past performance - **Total obligated, trailing 36 months (USAspending.gov):** $0 - **Award history:** 0 awards on record No federal prime awards on record (USAspending.gov). ## Proven teaming graph - No first-tier sub-award reports name this company yet - Source: USAspending.gov sub-award reports (FSRS), sync date not recorded. Prime contractors report first-tier subcontracts of $30,000 or more. Amounts are reported sub-award values. ## SBIR/STTR portfolio - SBIR/STTR awardee — Phase III-eligible for work derived from its SBIR/STTR projects - 14 SBIR/STTR awards totaling $5.5M: SBIR Phase I 7, SBIR Phase II 3, STTR Phase I 3, STTR Phase II 1 - By agency: Department of Defense 13, National Science Foundation 1 - Active projects (contract end date ahead): 1 - Phase II awards ending within 12 months: 1 - STTR Phase II, Department of Defense (Defense Health Agency), 2025, Mar 12, 2025 to Jul 11, 2027: Development of antibody treatment of MDR ESKAPE Pathogen, P. Aeruginosa. ($1,299,972) - STTR Phase I, Department of Defense (Defense Health Agency), 2024, Feb 29, 2024 to Sep 30, 2024: Development of antibody treatment of MDR ESKAPE Pathogen, P. aeruginosa ($249,992) - SBIR Phase II, Department of Defense (Office for Chemical and Biological Defense), 2023, May 22, 2023 to May 23, 2025: Development of Small Molecule Therapeutics Specifically Targeting Members of the Bunyavirales Order ($561,318) - STTR Phase I, Department of Defense (Office of the Secretary of Defense), 2023, Jan 16, 2023 to Jan 15, 2024: Non-canonical genetic code implementation with an optimized, easily scaled cell free lysate system ($249,990) - SBIR Phase I, Department of Defense (Office for Chemical and Biological Defense), 2022, Feb 18, 2022 to Aug 31, 2022: Development of novel Small Molecule Antiviral Endocytosis Inhibition pathway ($167,489) - STTR Phase I, Department of Defense (Army), 2020, Feb 12, 2020 to Nov 11, 2020: Ratiometric Quantification of Targeted Methylated DNA sites using MM-LAMP-OSD & Detection Devices ($166,500) - SBIR Phase II, Department of Defense (Defense Health Agency), 2018, Aug 27, 2018 to Jan 26, 2021: Field portable Coliform bacteria & E. Coli RNA biomarker LAMP - OSD system ($1,000,000) - SBIR Phase I, Department of Defense (Defense Health Agency), 2018, Jun 11, 2018 to Jan 10, 2019: Injectable Bio-compatible gel composed of iPSC derived NSC for regeneration of brain tissue ($149,999) - SBIR Phase I, Department of Defense (Defense Health Agency), 2017, Aug 15, 2017 to Mar 14, 2018: Field portable Coliform Bacteria and Escherichia Coli RNA expression LAMP-OSD detection system ($149,927) - SBIR Phase II, Department of Defense (Defense Health Agency), 2015, Apr 1, 2015 to Aug 31, 2014: Development of Extracellular Matrices for Cranioplasty Applications ($998,595) - Phase III: Agencies may award follow-on Phase III work without a new competition when it builds on this company’s earlier SBIR/STTR projects. Other work is competed as usual. - Source: SBIR.gov award data file, as of Nov 12, 2026 (file published Nov 1, 2026) ## FedRAMP offerings - No FedRAMP Marketplace listing is linked to this company - Source: FedRAMP Marketplace, sync date not recorded ## Exclusions & screening - Not yet checked against SAM.gov exclusions (search exclusions on SAM.gov: https://sam.gov/search/?index=ex) - Source: SAM.gov Exclusions, sync date not recorded - No confirmed match on the Consolidated Screening List (screened Nov 12, 2026) ## Contract vehicles on federal record - No contract-vehicle seats on federal record are linked to this company ## GSA CALC+ rates - No GSA CALC+ awarded ceiling rates on record for this company - Source: GSA CALC+ awarded ceiling rates, sync date not recorded. Ceiling rates are the most an agency can be charged, not prices paid ## Capabilities & differentiators No capability narrative published. ## Technical tags No technical tags published. ## Teaming preferences - Teaming preferences not published - **Teaming requests and NDAs:** request an introduction on the TeamingIndex profile (sign-in required): ## Business development contact No business-development contact published. ## Corporate hierarchy - No parent entity reported in SAM.gov - Affiliation with a parent or sister concerns can affect small-business size status (13 CFR 121.103). ## Provenance & disclaimer - **SAM.gov entity registration** (identifiers, NAICS/PSC, size and socio-economic status, hierarchy, registration and exclusion status): synced 2026-11-09 - **USAspending.gov** (prime award history and trailing 36-month obligations): nightly sync - **Contractor-provided profile** (capabilities, teaming preferences, self-attested compliance): not provided - **TeamingIndex verification** (credentials marked “Verified by TeamingIndex”): no verified credentials on record; methodology: - **Blind SPRS:** exact NIST SP 800-171 SPRS scores are published only when the contractor opts in; brackets are cumulative thresholds (SPRS ≥ 0, SPRS ≥ 50, SPRS ≥ 70, SPRS ≥ 85, SPRS ≥ 95, SPRS ≥ 105, SPRS = 110 (perfect)). - **Before award:** self-attested facts have not been independently verified. Confirm registration and exclusions in SAM.gov, CMMC status and SPRS assessment currency with the contractor (DFARS 252.204-7019, -7020 and -7021), facility clearances through DCSA’s NISS, AS9100-series certificates in the IAQG OASIS database, and FedRAMP authorizations on the FedRAMP Marketplace. - **Zero CUI:** this document contains no Controlled Unclassified Information. TeamingIndex stores verification metadata only, never SSPs, POA&Ms or DD Form 254s. - **Machine-readable:** schema.org JSON-LD is embedded in ; this twin: ; site index: © 2026 HILARTECH, LLC. All rights reserved. TeamingIndex.com is an independent defense industrial base intelligence platform owned and operated by HILARTECH, LLC and is not affiliated with or endorsed by the U.S. Department of Defense (DoD), the General Services Administration (GSA), or SAM.gov.